UAB research team sets sights on new era in neuroprotection

soccertese · 10-15-2012, 05:19 PM

http://www.uab.edu/news/latest/item/...europrotection

Conductor71 · 10-17-2012, 09:57 AM

Quote:

Originally Posted by soccertese

http://www.uab.edu/news/latest/item/...europrotection

Thanks, but looks like this only applies if you have LRRK2 genetic form of PD. I am really beginning to resent this sort of press release from academia because they mislead through over inflating the potential benefit of treatments that target genetic specific PD, not sporadic PD. This is just one of many.

“We don’t yet know what percentage of patients might benefit from LRKK2 inhibitors."

In fact, I am beginning that this is going to be the way we see treatment improvements...those who have the genetic form benefit while the rest of us try it on for size...ggrrrr.

soccertese · 10-17-2012, 10:10 AM

LOL
the curse of the internet! gotta take the good with the bad. press releases might be self promotion for the researcher and institution but i'd rather see their findings sooner than later rather than wait for a monthly/quarterly journal option or conference as they would have had to pre-internet.
not sure if they are directed towards laypeople or parkies but more towards informing colleagues in the field, drug companies, grad students looking for a position?, researchers looking for a job, donors?

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
International Oversight Team Sets Standards for Stem Cell trials	leonore	Parkinson's Disease	0	12-09-2008 06:25 PM

Site Navigation

NeuroTalk Online Support Groups

UAB research team sets sights on new era in neuroprotection

NeuroTalk Forums